National University Cancer Institute, Singapore

Unlock the next frontier of clinical excellence at the International Surgical Oncology Symposium, 6 to 7 September 2024! Sharpen your skills, expand your network, and immerse in the latest surgical developments through transformative discussions. The highly anticipated Session Five will feature plenary talks from three of the brightest minds in healthcare - Dr Sheraz Markar, Dr Anita Balakrishnan and Dr Ayesha Khanna. Brace yourself for high-impact perspectives on AI, big data, and the future of clinical trials. 1️⃣ Using Machine Learning and AI in Transnational Sciences 2️⃣ Designing Trials in the Era of Big Data, Machine Learning, and Large Language Models 3️⃣ Large Language Models in Healthcare: Could It All Go Wrong? 📌 Elevate your practice and join us: https://for.sg/isos2024 #ISOS2024 #SurgicalOncology #AIinHealthcare #InnovationInHealthcare #TechInHealthcare #BigData

Are you ready for The Future of Multidisciplinary Meetings? A robot assistant is ready to assist you. 🤖 Find out more at the International Surgical Oncology Symposium during Session Four: Augmented Reality and Tumour Boards, where Dr Serene Goh will present on 'AI for Postoperative Recommendations for Breast Cancer (:arge Language Model)', and Prof Jimmy So will discuss on 'AskBob: AI Tumour Board for Esophagogastric Cancers'. Don't miss your chance to join this exciting yet forward-thinking session! ➡ Register now: https://for.sg/isos2024 #ISOS2024 #SurgicalOncology #AIinHealthcare #FutureOfHealthcare #InnovationInHealthcare #TumourBoard #AugmentedReality

🚨 Two more days to the 3rd International Surgical Oncology Symposium!* We are excited to introduce Session Four: Augmented Reality and Tumour Boards, which will be the opening for the 2nd day of #ISOS2024, where innovation meets real-world surgical applications. This session features three clinical specialists who will delve into the transformative power of mixed reality in surgery. Topics covered: 1️⃣ The current and future status of mixed reality surgery, by Dr Gao Yujia 2️⃣ Use case: mixed reality in thoracic surgery, by Dr Lowell Leow 3️⃣ Use case: mixed reality in neurosurgery, by Dr Swati Jain 🎯 Special segment: Live audience participation with ten HoloLens units, demonstrated by Dr Gao and his team! Don't miss this opportunity to engage with the future of surgery! Register now: https://for.sg/isos2024 #ISOS2024 #SurgicalOncology #MixedRealitySurgery #AIinHealthcare

It's going to be a power-packed first day for the International Surgical Oncology Symposium on 6 September, Friday! The momentum will continue and lead into Session Three's plenary talks and a fireside chat. 💪 Learn from and engage with thought leaders Adj Prof Ngiam Kee Yuan, Dr Ayesha Khanna, Dr Zubin Daruwalla and Mr Ujjwal Kumar in the areas of AI and healthcare innovation! Plenary topics will include: 1️⃣ Unlocking the Power of AI In Healthcare 2️⃣ Global Health Industry Trends and the Evolution of Healthcare 3️⃣ Overcoming Hardware and Connectivity in Building a Future AI-Enabled Healthcare System 4️⃣ Building the Infrastructure to Harness AI In a Healthcare System: An Efficient Build? This session will round up with a Fireside discussion, offering a deep dive into the innovations reshaping surgical oncology and healthcare at large. ➡ Secure your spot now: https://for.sg/isos2024 #ISOS2024 #AIinHealthcare #HealthTech #HealthcareTrends #FutureOfHealthcare #SurgicalOncology #InnovationInHealthcare

Gearing up for this Friday's International Surgical Oncology Symposium (ISOS), where we're looking forward to plenty of exciting and thought-provoking conversations about AI and technology in the field of Surgical Oncology! Session Two: Harnessing AI in Preoperative Planning Join us for the first half of the afternoon as we have four international and local healthcare professionals Dr Sheraz Markar, Dr Sonal Asthana, Dr Anita Balakrishnan and Dr Johnny Ong diving into groundbreaking topics, comprising: 1️⃣ State of The Art: The Current and Future Application of Artificial Intelligence in Big Data and Trial Design 2️⃣ Artificial Intelligence and Augmented Reality in the Surgical Field 3️⃣ Large Cohort Studies Are Improving the Care of Patients in the Era of Precision Medicine 4️⃣ Improving Outcomes in Peritoneal Disease: The Potential For AI 🔎 These sessions promise to shed light on the cutting-edge advancements transforming surgical oncology. 💡 Register today at https://for.sg/isos2024 #ISOS2024 #SurgicalOncology #AIinHealthcare #PrecisionMedicine #AugmentedReality #BigData #PeritonealDisease

Three more sleeps to the 3rd edition of the International Surgical Oncology Symposium 2024! From 6 to 7 September, the two-day programme will revolve around the theme 'Blades and Bytes - how AI & Technology is harnessed in Surgical Oncology', dissected by a panel of international and local distinguished speakers.   Session One: State of the Art of AI in clinical practice   ️Our experts will explore two critical subtopics: 1️⃣ *The Future of the Surgeon and Oncologist in the Era of AI: The Promise and the Pitfalls* - A thought-provoking discussion on how AI is reshaping the roles of healthcare professionals, balancing innovation with ethical considerations. 2️⃣ *Early Detection of Cancer Using Large Language Models* - Discover how AI is pushing the boundaries of early diagnosis and what this means for the future of cancer care.    Join us to gain cutting-edge insights into how AI is revolutionising oncology and the potential challenges ahead.   ➡ Don't miss out and register today: https://for.sg/isos2024   #TeamNCIS #SurgicalOncology #AIinHealthCare #ISOS2024

🌟TeamNCIS at BPOF-APGCS - 2nd Biomarkers and Precision Oncology Forum & 11th Asia Pacific Gastroenterology Cancer: Advancing the Future of Cancer Care!🌟 #TeamNCIS has had a dynamic week, starting with our impactful presentations at the Biomarkers and Precision Oncology Forum (BPOF), and continuing our momentum at the Asia-Pacific Gastroesophageal Cancer Summit (APGCS) 2024. ⚗BPOF highlights: Our team presented on the critical role of biomarkers and precision oncology, showcasing how personalised medicine is transforming cancer treatment. The insights shared emphasised the importance of tailored therapies that improve patient outcomes. 🔬 APGCS highlights: Building on our BPOF presentations, we were at the forefront at APGCS, delivering keynote lectures, plenary talks, and panel discussions focused on the latest advancements in cancer care. Our contributions highlighted cutting-edge research, innovative treatment approaches, and the importance of global collaboration in oncology. These back-to-back events provided an incredible platform for sharing knowledge, fostering collaboration, and driving innovation in cancer research and treatment. We are proud of the impact #TeamNCIS has made and excited for the future of oncology. A big thank you to all the participants, organisers, and our fellow colleagues for making these events a success. Together, we’re paving the way for better cancer care worldwide. #TeamNCIS: Adj A/Prof Cheng Ean Chee, Medical Oncology Prof Lee Soo Chin, Medical Oncology Dr Alvin Wong, Medical Oncology Dr Andrea Wong, Medical Oncology A/Prof David SP Tan, Medical Oncology Dr Samuel Ow, Medical Oncology Dr Joline Lim, Medical Oncology Dr Raghav Sundar MBBS, PhD, Medical Oncology Dr Wei Peng Yong, Medical Oncology A/Prof Alfred Kow, Surgical Oncology Dr Bala Vellayappan, Radiation Oncology Dr Robert Walsh, Medical Oncology #CancerResearch #PrecisionOncology #Biomarkers #Oncology #TeamNCIS #BPOF2024 #APGCS2024 #InnovationInHealth

We are incredibly proud to have our Executive Director, Adj A/Prof Cheng Ean Chee, taking the stage tomorrow as a panellist for two critical sessions on colorectal cancer (CRC) - 'Challenging Cases in Metastatic CRC', and 'Round Table Discussion on Multidisciplinary Team Case' at the 11th Asia-Pacific Gastroenterology Cancer Summit 2024. Additionally, she is one of three speakers at a featured symposium, 'Case Study Deep Dive in BRAF Mutant mCRC' on the final day of this influential 3-day event. This summit is a testament to the remarkable talent within #TeamNCIS. Numerous colleagues have made their mark contributing to previous sessions, highlighting the depth of knowledge and innovation we bring to the healthcare industry. It is a honour to see the team's expertise recognised on such an esteemed platform. We look forward to insightful discussions that will impact the future of cancer care in Asia Pacific and beyond. #APGCS2024

We're halfway through the second day of the Asia Pacific Gastroenterology Cancer Summit, and #TeamNCIS continues to shine. 💫 This morning, Dr Robert Walsh, Associate Consultant, Dept of Haematology-Oncology, expertly moderated a session on 'Multidisciplinary Management of Locally Advanced Gastroesophageal Cancers,' with key insights from Dr Bala Vellayappan, Senior Consultant, Dept of Radiation Oncology and other clinical experts from the region. Don't miss this afternoon's session! Catch A/Prof Alfred Kow, Senior Consultant, Div of Surgical Oncology, where he will delve into the latest advancements in High Dose Locoregional Radiation and Conversion Therapy with fellow specialists in GI cancer. Secure your spot now at https://lnkd.in/dkPwh5Y

The 11th Asia-Pacific Gastroenterology Cancer Summit 2024 has kicked off! We're excited to have a strong #TeamNCIS participation in #APGCS2024, bringing to the table their extensive expertise and experience. Not to be missed - look out for tomorrow's session "In Conversation with the Experts: Critical Updates in Upper GI Malignancies", where Dr Raghav Sundar MBBS, PhD, Senior Consultant, Dept of Haematology-Oncology at NCIS will join a panel of specialists as they deep dive into the latest breakthroughs in Gastrointestinal (GI) Oncology.